Heregulin-|[beta]|1 regulates the estrogen receptor-|[alpha]| gene expression and activity via the ErbB2|[sol]|PI 3-K|[sol]|Akt pathway

This study examines whether the serine/threonine protein kinase, Akt, is involved in the crosstalk between the ErbB2 and estrogen receptor- (ER-) pathways. Treatment of MCF-7 cells with 10-9 M heregulin-1 (HRG-1) resulted in a rapid phosphorylation of Akt and a 15-fold increase in Akt activity. Akt phosphorylation was blocked by inhibitors of phosphatidylinositol 3-kinase (PI 3-K), by antiestrogens, the protein tyrosine kinase inhibitor, genistein, and by AG825, a selective ErbB2 inhibitor; but not by AG30, a selective EGFR inhibitor. Akt phosphorylation by HRG-1 was abrogated by an arginine to cysteine mutation (R25C) in the pleckstrin homology (PH) domain of Akt, and HRG-1 did not induce Akt phosphorylation in the ER-negative variant of MCF-7, MCF-7/ADR. Transient transfection of ER- into these cells restored Akt phosphorylation by HRG-1, suggesting the requirement of ER-. HRG-1 did not activate Akt in MCF-7 cells stably transfected with an anti-ErbB2-targeted ribozyme, further confirming a role for ErbB2. Stable transfection of the cells with a dominant negative Akt or with the R25C-Akt mutant, as well as PI 3-K inhibitors, blocked the effect of HRG-1 on ER- expression and activity and on the growth of MCF-7 cells. Stable transfection of MCF-7 cells with a constitutively active Akt mimicked the effect of HRG-1. Experiments employing selective ErbB inhibitors demonstrate that the effect of HRG-1 on ER- expression and activity is also mediated by ErbB2 and not by EGFR, demonstrating that ErbB2 is the primary mediator of the effects of HRG-1 on ER- regulation. Taken together, our data suggest that HRG-1, bound to the ErbB2 ErbB3 heterodimer, in the presence of membrane ER-, interacts with and activates PI 3-K/Akt. Akt leads to nuclear ER- phosphorylation, thereby altering its expression and transcriptional activity.